Boston Scientific Stresses Cardiology R&D, Makes Over Business Units
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's planned launches of IVUS systems, cutting balloons and embolic protection devices will allow the firm to buttress its drug-eluting stent offering with core cardiovascular growth